John D. Roache - Publications

Affiliations: 
The University of Texas Graduate School of Biomedical Sciences at Houston 
Area:
Neuroscience Biology

114 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2016 Javors MA, Hill-Kapturczak N, Roache JD, Karns-Wright TE, Dougherty DM. Characterization of the Pharmacokinetics of Phosphatidylethanol 16:0/18:1 and 16:0/18:2 in Human Whole Blood After Alcohol Consumption in a Clinical Laboratory Study. Alcoholism, Clinical and Experimental Research. PMID 27130527 DOI: 10.1111/Acer.13062  0.32
2016 Dondanville KA, Blankenship AE, Molino A, Resick PA, Wachen JS, Mintz J, Yarvis JS, Litz BT, Borah EV, Roache JD, Young-McCaughan S, Hembree EA, Peterson AL. Qualitative examination of cognitive change during PTSD treatment for active duty service members. Behaviour Research and Therapy. 79: 1-6. PMID 26874683 DOI: 10.1016/J.Brat.2016.01.003  0.32
2016 Mullen J, Mathias CW, Karns TE, Liang Y, Hill-Kapturczak N, Roache JD, Lamb RJ, Dougherty DM. Behavioral Impulsivity Does Not Predict Naturalistic Alcohol Consumption or Treatment Outcomes Addictive Disorders and Their Treatment. DOI: 10.1097/ADT.0000000000000085  0.32
2015 Roache JD, Karns TE, Hill-Kapturczak N, Mullen J, Liang Y, Lamb RJ, Dougherty DM. Using Transdermal Alcohol Monitoring to Detect Low-Level Drinking. Alcoholism, Clinical and Experimental Research. 39: 1120-7. PMID 25988708 DOI: 10.1111/Acer.12750  0.32
2015 Resick PA, Wachen JS, Mintz J, Young-McCaughan S, Roache JD, Borah AM, Borah EV, Dondanville KA, Hembree EA, Litz BT, Peterson AL. A Randomized Clinical Trial of Group Cognitive Processing Therapy Compared With Group Present-Centered Therapy for PTSD Among Active Duty Military Personnel. Journal of Consulting and Clinical Psychology. PMID 25939018 DOI: 10.1037/Ccp0000016  0.32
2015 Dougherty DM, Lake SL, Hill-Kapturczak N, Liang Y, Karns TE, Mullen J, Roache JD. Using contingency management procedures to reduce at-risk drinking in heavy drinkers. Alcoholism, Clinical and Experimental Research. 39: 743-51. PMID 25833033 DOI: 10.1111/Acer.12687  0.32
2015 Anderson AL, Li SH, Markova D, Holmes TH, Chiang N, Kahn R, Campbell J, Dickerson DL, Galloway GP, Haning W, Roache JD, Stock C, Elkashef AM. Bupropion for the treatment of methamphetamine dependence in non-daily users: a randomized, double-blind, placebo-controlled trial. Drug and Alcohol Dependence. 150: 170-4. PMID 25818061 DOI: 10.1016/j.drugalcdep.2015.01.036  0.32
2015 Lake SL, Hill-Kapturczak N, Liang Y, Roache JD, Mullen J, Karns TE, Dougherty DM. Assessing the Validity of Participant-Derived Compared to Staff-Derived Values to Compute a Binge Score. Alcohol and Alcoholism (Oxford, Oxfordshire). 50: 413-9. PMID 25770137 DOI: 10.1093/Alcalc/Agv018  0.32
2015 Dougherty DM, Mullen J, Hill-Kapturczak N, Liang Y, Karns TE, Lake SL, Mathias CW, Roache JD. Effects of tryptophan depletion and a simulated alcohol binge on impulsivity. Experimental and Clinical Psychopharmacology. 23: 109-21. PMID 25730415 DOI: 10.1037/A0038943  0.32
2015 Dougherty DM, Karns TE, Mullen J, Liang Y, Lake SL, Roache JD, Hill-Kapturczak N. Transdermal alcohol concentration data collected during a contingency management program to reduce at-risk drinking. Drug and Alcohol Dependence. 148: 77-84. PMID 25582388 DOI: 10.1016/J.Drugalcdep.2014.12.021  0.32
2015 Hill-Kapturczak N, Roache JD, Liang Y, Karns TE, Cates SE, Dougherty DM. Accounting for sex-related differences in the estimation of breath alcohol concentrations using transdermal alcohol monitoring. Psychopharmacology. 232: 115-23. PMID 24923985 DOI: 10.1007/S00213-014-3644-9  0.32
2015 Dougherty DM, Karns TE, Mullen J, Liang Y, Lake SL, Roache JD, Hill-Kapturczak N. Corrigendum to "Transdermal alcohol concentration data collected during a contingency management program to reduce at-risk drinking" [Drug and Alcohol Dependence, 148, (2015), 77-84 doi: 10.1016/j.drugalcdep.2014.12.021] Drug and Alcohol Dependence. 149: 304. DOI: 10.1016/J.Drugalcdep.2015.01.037  0.32
2014 Hill-Kapturczak N, Lake SL, Roache JD, Cates SE, Liang Y, Dougherty DM. Do variable rates of alcohol drinking alter the ability to use transdermal alcohol monitors to estimate peak breath alcohol and total number of drinks? Alcoholism, Clinical and Experimental Research. 38: 2517-22. PMID 25335857 DOI: 10.1111/Acer.12528  0.32
2014 Dougherty DM, Hill-Kapturczak N, Liang Y, Karns TE, Cates SE, Lake SL, Mullen J, Roache JD. Use of continuous transdermal alcohol monitoring during a contingency management procedure to reduce excessive alcohol use. Drug and Alcohol Dependence. 142: 301-6. PMID 25064019 DOI: 10.1016/J.Drugalcdep.2014.06.039  0.32
2014 Dougherty DM, Hill-Kapturczak N, Liang Y, Karns TE, Lake SL, Cates SE, Roache JD. The Potential Clinical Utility of Transdermal Alcohol Monitoring Data to Estimate the Number of Alcoholic Drinks Consumed Addictive Disorders and Their Treatment. DOI: 10.1097/ADT.0000000000000060  0.32
2013 Somoza EC, Winship D, Gorodetzky CW, Lewis D, Ciraulo DA, Galloway GP, Segal SD, Sheehan M, Roache JD, Bickel WK, Jasinski D, Watson DW, Miller SR, Somoza P, Winhusen T. A multisite, double-blind, placebo-controlled clinical trial to evaluate the safety and efficacy of vigabatrin for treating cocaine dependence. Jama Psychiatry. 70: 630-7. PMID 23575810 DOI: 10.1001/jamapsychiatry.2013.872  0.32
2013 Peterson AL, Roache JD, Raj J, Young-McCaughan S. The need for expanded monitoring of adverse events in behavioral health clinical trials. Contemporary Clinical Trials. 34: 152-4. PMID 23117077 DOI: 10.1016/J.Cct.2012.10.009  0.32
2013 Johnson BA, Roache JD, Ait-Daoud N, Gunderson EW, Haughey HM, Wang XQ, Liu L. Topiramate's effects on cocaine-induced subjective mood, craving and preference for money over drug taking. Addiction Biology. 18: 405-16. PMID 23039088 DOI: 10.1111/J.1369-1600.2012.00499.X  0.32
2012 McCammon MG, Fogg TT, Jacobsen L, Roache J, Sampson R, Bower CL. From free to free market: cost recovery in federally funded clinical research. Science Translational Medicine. 4: 141cm7. PMID 22764204 DOI: 10.1126/scitranslmed.3003589  0.32
2012 Roache JD. Commentary on comparison of alcoholism subtypes as moderators of the response to sertraline treatment. Alcoholism, Clinical and Experimental Research. 36: 561-3. PMID 22432698 DOI: 10.1111/j.1530-0277.2012.01781.x  0.32
2012 Ait-Daoud N, Seneviratne C, Smith JB, Roache JD, Dawes MA, Liu L, Wang XQ, Johnson BA. Preliminary Evidence for cue-induced Alcohol Craving Modulated by Serotonin Transporter Gene Polymorphism rs1042173. Frontiers in Psychiatry. 3: 6. PMID 22355291 DOI: 10.3389/Fpsyt.2012.00006  0.32
2011 Roache JD, Kahn R, Newton TF, Wallace CL, Murff WL, De La Garza R, Rivera O, Anderson A, Mojsiak J, Elkashef A. A double-blind, placebo-controlled assessment of the safety of potential interactions between intravenous cocaine, ethanol, and oral disulfiram. Drug and Alcohol Dependence. 119: 37-45. PMID 21696894 DOI: 10.1016/J.Drugalcdep.2011.05.015  0.32
2011 Johnson BA, Ait-Daoud N, Seneviratne C, Roache JD, Javors MA, Wang XQ, Liu L, Penberthy JK, DiClemente CC, Li MD. Pharmacogenetic approach at the serotonin transporter gene as a method of reducing the severity of alcohol drinking. The American Journal of Psychiatry. 168: 265-75. PMID 21247998 DOI: 10.1176/Appi.Ajp.2010.10050755  0.32
2009 Dawes MA, Roache JD, Javors MA, Bergeson SE, Richard DM, Mathias CW, Ait-Daoud N, Dougherty DM, Johnson BA. Drinking histories in alcohol-use-disordered youth: preliminary findings on relationships to platelet serotonin transporter expression with genotypes of the serotonin transporter. Journal of Studies On Alcohol and Drugs. 70: 899-907. PMID 19895766 DOI: 10.15288/Jsad.2009.70.899  0.32
2009 Anderson AL, Reid MS, Li SH, Holmes T, Shemanski L, Slee A, Smith EV, Kahn R, Chiang N, Vocci F, Ciraulo D, Dackis C, Roache JD, Salloum IM, Somoza E, et al. Modafinil for the treatment of cocaine dependence. Drug and Alcohol Dependence. 104: 133-9. PMID 19560290 DOI: 10.1016/J.Drugalcdep.2009.04.015  0.32
2009 Ait-Daoud N, Roache JD, Dawes MA, Liu L, Wang XQ, Javors MA, Seneviratne C, Johnson BA. Can serotonin transporter genotype predict craving in alcoholism? Alcoholism, Clinical and Experimental Research. 33: 1329-35. PMID 19426172 DOI: 10.1111/J.1530-0277.2009.00962.X  0.32
2008 Roache JD, Wang Y, Ait-Daoud N, Johnson BA. Prediction of serotonergic treatment efficacy using age of onset and Type A/B typologies of alcoholism. Alcoholism, Clinical and Experimental Research. 32: 1502-12. PMID 18565156 DOI: 10.1111/J.1530-0277.2008.00717.X  0.32
2008 Johnson BA, Javors MA, Roache JD, Seneviratne C, Bergeson SE, Ait-Daoud N, Dawes MA, Ma JZ. Can serotonin transporter genotype predict serotonergic function, chronicity, and severity of drinking? Progress in Neuro-Psychopharmacology & Biological Psychiatry. 32: 209-16. PMID 17950969 DOI: 10.1016/J.Pnpbp.2007.07.030  0.32
2008 Ginsburg BC, Gerak LR, McMahon LR, Roache JD. Neurosteroids in alcohol and substance use Neuroactive Steroids in Brain Function, Behavior and Neuropsychiatric Disorders: Novel Strategies For Research and Treatment. 509-538. DOI: 10.1007/978-1-4020-6854-6_25  0.32
2007 Carter LP, Griffiths RR, Suess PE, Casada JH, Wallace CL, Roache JD. Relative abuse liability of indiplon and triazolam in humans: a comparison of psychomotor, subjective, and cognitive effects. The Journal of Pharmacology and Experimental Therapeutics. 322: 749-59. PMID 17502431 DOI: 10.1124/Jpet.107.119693  0.32
2007 Johnson BA, Wells LT, Roache JD, Wallace CL, Ait-Daoud N, Dawes MA, Liu L, Wang XQ, Javors MA. Kinetic and cardiovascular effects of acute topiramate dosing among non-treatment-seeking, methamphetamine-dependent individuals. Progress in Neuro-Psychopharmacology & Biological Psychiatry. 31: 455-61. PMID 17184890 DOI: 10.1016/J.Pnpbp.2006.11.011  0.32
2007 Johnson BA, Roache JD, Ait-Daoud N, Wells LT, Wallace CL, Dawes MA, Liu L, Wang XQ. Effects of topiramate on methamphetamine-induced changes in attentional and perceptual-motor skills of cognition in recently abstinent methamphetamine-dependent individuals. Progress in Neuro-Psychopharmacology & Biological Psychiatry. 31: 123-30. PMID 16978753 DOI: 10.1016/J.Pnpbp.2006.08.002  0.32
2007 Johnson BA, Roache JD, Ait-Daoud N, Wells LT, Wallace CL, Dawes MA, Liu L, Wang XQ. Effects of acute topiramate dosing on methamphetamine-induced subjective mood. The International Journal of Neuropsychopharmacology / Official Scientific Journal of the Collegium Internationale Neuropsychopharmacologicum (Cinp). 10: 85-98. PMID 16448579 DOI: 10.1017/S1461145705006401  0.32
2006 Casada JH, Roache JD. Dissociation of physiology and behavior in PTSD International Journal of Psychophysiology. 62: 243-248. PMID 16814888 DOI: 10.1016/J.Ijpsycho.2006.04.005  0.32
2006 Johnson BA, Roache JD, Ait-Daoud N, Javors MA, Harrison JM, Elkashef A, Mojsiak J, Li SH, Bloch DA. A preliminary randomized, double-blind, placebo-controlled study of the safety and efficacy of ondansetron in the treatment of cocaine dependence. Drug and Alcohol Dependence. 84: 256-63. PMID 16631323 DOI: 10.1016/J.Drugalcdep.2006.02.011  0.32
2006 Newton TF, Roache JD, De La Garza R, Fong T, Wallace CL, Li SH, Elkashef A, Chiang N, Kahn R. Bupropion reduces methamphetamine-induced subjective effects and cue-induced craving. Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology. 31: 1537-44. PMID 16319910 DOI: 10.1038/Sj.Npp.1300979  0.32
2005 Roache JD, Johnson BA, Ait-Daoud N, Mauldin JB, Thornton JE, Wells LT, Murff WL. Effects of repeated-dose isradipine on the abuse liability of cocaine. Experimental and Clinical Psychopharmacology. 13: 319-26. PMID 16366762 DOI: 10.1037/1064-1297.13.4.319  0.32
2005 Johnson BA, Ait-Daoud N, Roache JD. The COMBINE SAFTEE: a structured instrument for collecting adverse events adapted for clinical studies in the alcoholism field. Journal of Studies On Alcohol. Supplement. 157-67; discussion 1. PMID 16223067 DOI: 10.15288/Jsas.2005.S15.157  0.32
2005 Newton TF, Roache JD, De La Garza R, Fong T, Wallace CL, Li SH, Elkashef A, Chiang N, Kahn R. Safety of intravenous methamphetamine administration during treatment with bupropion. Psychopharmacology. 182: 426-35. PMID 16163531 DOI: 10.1007/S00213-005-0102-8  0.32
2005 Johnson BA, Wells LT, Roache JD, Wallace C, Ait-Daoud N, Wang Y. Isradipine decreases the hemodynamic response of cocaine and methamphetamine results from two human laboratory studies: results from two human laboratory studies. American Journal of Hypertension. 18: 813-22. PMID 15925741 DOI: 10.1016/J.Amjhyper.2005.01.020  0.32
2005 Johnson BA, Roache JD, Ait-Daoud N, Wallace CL, Wells LT, Wang Y, Dawes MA. Effects of isradipine on cocaine-induced changes in cognitive performance in recently abstinent cocaine-dependent individuals. The International Journal of Neuropsychopharmacology / Official Scientific Journal of the Collegium Internationale Neuropsychopharmacologicum (Cinp). 8: 549-56. PMID 15916717 DOI: 10.1017/S1461145705005511  0.32
2005 Johnson BA, Roache JD, Ait-Daoud N, Wallace C, Wells L, Dawes M, Wang Y. Effects of isradipine, a dihydropyridine-class calcium-channel antagonist, on d-methamphetamine's subjective and reinforcing effects. The International Journal of Neuropsychopharmacology / Official Scientific Journal of the Collegium Internationale Neuropsychopharmacologicum (Cinp). 8: 203-13. PMID 15850499 DOI: 10.1017/S1461145704005036  0.32
2005 Wurst FM, Alling C, Aradottir S, Pragst F, Allen JP, Weinmann W, Marmillot P, Ghosh P, Lakshman R, Skipper GE, Neumann T, Spies C, Javors M, Johnson BA, Ait-Daoud N, ... ... Roache JD, et al. Emerging biomarkers: new directions and clinical applications. Alcoholism, Clinical and Experimental Research. 29: 465-73. PMID 15770123 DOI: 10.1097/01.Alc.0000156082.08248.Ab  0.32
2005 Johnson BA, Dawes MA, Roache JD, Wells LT, Ait-Daoud N, Mauldin JB, Wang Y, Lancaster JL, Fox PT. Acute intravenous low- and high-dose cocaine reduces quantitative global and regional cerebral blood flow in recently abstinent subjects with cocaine use disorder. Journal of Cerebral Blood Flow and Metabolism : Official Journal of the International Society of Cerebral Blood Flow and Metabolism. 25: 928-36. PMID 15758948 DOI: 10.1038/Sj.Jcbfm.9600093  0.32
2005 Casada JH, Roache JD. Behavioral inhibition and activation in posttraumatic stress disorder. The Journal of Nervous and Mental Disease. 193: 102-9. PMID 15684912 DOI: 10.1097/01.Nmd.0000152809.20938.37  0.32
2005 Johnson BA, Javors MA, Lam YW, Wells LT, Tiouririne M, Roache JD, Ait-Daoud N, Lawson K. Kinetic and cardiovascular comparison of immediate-release isradipine and sustained-release isradipine among non-treatment-seeking, cocaine-dependent individuals. Progress in Neuro-Psychopharmacology & Biological Psychiatry. 29: 15-20. PMID 15610940 DOI: 10.1016/J.Pnpbp.2004.08.014  0.32
2005 Javors MA, Seneviratne C, Roache JD, Ait-Daoud N, Bergeson SE, Walss-Bass MC, Akhtar FZ, Johnson BA. Platelet serotonin uptake and paroxetine binding among allelic genotypes of the serotonin transporter in alcoholics. Progress in Neuro-Psychopharmacology & Biological Psychiatry. 29: 7-13. PMID 15610939 DOI: 10.1016/J.Pnpbp.2004.08.004  0.32
2005 Johnson BA, Roache JD, Ait-Daoud N, Wallace C, Wells LT, Wang Y. Effects of isradipine on methamphetamine-induced changes in attentional and perceptual-motor skills of cognition. Psychopharmacology. 178: 296-302. PMID 15452681 DOI: 10.1007/S00213-004-1998-0  0.32
2004 Johnson BA, Roache JD, Ait-Daoud N, Wells LT, Mauldin JB. Effects of isradipine on cocaine-induced subjective mood. Journal of Clinical Psychopharmacology. 24: 180-91. PMID 15206666 DOI: 10.1097/01.Jcp.0000115662.45074.C3  0.32
2004 Pearson DA, Lane DM, Santos CW, Casat CD, Jerger SW, Loveland KA, Faria LP, Mansour R, Henderson JA, Payne CD, Roache JD, Lachar D, Cleveland LA. Effects of methylphenidate treatment in children with mental retardation and ADHD: individual variation in medication response. Journal of the American Academy of Child and Adolescent Psychiatry. 43: 686-98. PMID 15167085 DOI: 10.1097/01.Chi.0000120024.14101.96  0.32
2004 Pearson DA, Santos CW, Casat CD, Lane DM, Jerger SW, Roache JD, Loveland KA, Lachar D, Faria LP, Payne CD, Cleveland LA. Treatment effects of methylphenidate on cognitive functioning in children with mental retardation and ADHD. Journal of the American Academy of Child and Adolescent Psychiatry. 43: 677-85. PMID 15167084 DOI: 10.1097/01.Chi.0000124461.81324.13  0.32
2004 McBride WJ, Lovinger DM, Machu T, Thielen RJ, Rodd ZA, Murphy JM, Roache JD, Johnson BA. Serotonin-3 receptors in the actions of alcohol, alcohol reinforcement, and alcoholism. Alcoholism, Clinical and Experimental Research. 28: 257-67. PMID 15112933 DOI: 10.1097/01.Alc.0000113419.99915.Da  0.32
2004 Lam YW, Javors MA, Ait-Daoud N, Roache JD, Johnson BA. Relative bioavailability of an extemporaneous ondansetron 4-mg capsule formulation versus solution. Pharmacotherapy. 24: 477-81. PMID 15098801 DOI: 10.1592/Phco.24.5.477.33353  0.32
2003 Sloan TB, Roache JD, Johnson BA. The role of anxiety in predicting drinking behaviour. Alcohol and Alcoholism (Oxford, Oxfordshire). 38: 360-3. PMID 12814905 DOI: 10.1093/Alcalc/Agg090  0.32
2003 Johnson BA, Ait-Daoud N, Bowden CL, DiClemente CC, Roache JD, Lawson K, Javors MA, Ma JZ. Oral topiramate for treatment of alcohol dependence: a randomised controlled trial. Lancet. 361: 1677-85. PMID 12767733 DOI: 10.1016/S0140-6736(03)13370-3  0.32
2003 Pearson DA, Santos CW, Roache JD, Casat CD, Loveland KA, Lachar D, Lane DM, Faria LP, Cleveland LA. Treatment effects of methylphenidate on behavioral adjustment in children with mental retardation and ADHD. Journal of the American Academy of Child and Adolescent Psychiatry. 42: 209-16. PMID 12544181 DOI: 10.1097/00004583-200302000-00015  0.32
2002 Gomez TH, Roache JD, Meisch RA. Relative reinforcing effects of different benzodiazepine doses for rhesus monkeys. Drug and Alcohol Dependence. 68: 275-83. PMID 12393222 DOI: 10.1016/S0376-8716(02)00222-3  0.32
2002 Johnson BA, Roache JD, Ait-Daoud N, Zanca NA, Velazquez M. Ondansetron reduces the craving of biologically predisposed alcoholics. Psychopharmacology. 160: 408-13. PMID 11919668 DOI: 10.1007/S00213-002-1002-9  0.32
2001 Ait-Daoud N, Johnson BA, Javors M, Roache JD, Zanca NA. Combining ondansetron and naltrexone treats biological alcoholics: corroboration of self-reported drinking by serum carbohydrate deficient transferrin, a biomarker. Alcoholism, Clinical and Experimental Research. 25: 847-9. PMID 11410720 DOI: 10.1111/J.1530-0277.2001.Tb02289.X  0.32
2000 Johnson BA, Roache JD, Javors MA, Diclemente CC, Cloninger CR, Prihoda TJ, Bordnick PS, Ait-Daoud N, Hensler J. Ondansetron for reduction of drinking among biologically predisposed alcoholic patients: A randomized controlled trial Journal of the American Medical Association. 284: 963-971. PMID 10944641 DOI: 10.1001/Jama.284.8.963  0.32
2000 Johnson BA, Cloninger CR, Roache JD, Bordnick PS, Ruiz P. Age of onset as a discriminator between alcoholic subtypes in a treatment-seeking outpatient population American Journal On Addictions. 9: 17-27. PMID 10914290 DOI: 10.1080/10550490050172191  0.32
2000 Harris JT, Roache JD, Thornton JE. A role for valproate in the treatment of sedative-hypnotic withdrawal and for relapse prevention Alcohol and Alcoholism. 35: 319-323. PMID 10905994 DOI: 10.1093/Alcalc/35.4.319  0.32
2000 Roache JD, Grabowski J, Schmitz JM, Creson DL, Rhoades HM. Laboratory measures of methylphenidate effects in cocaine-dependent patients receiving treatment Journal of Clinical Psychopharmacology. 20: 61-68. PMID 10653210 DOI: 10.1097/00004714-200002000-00011  0.32
1999 Oswald LM, Roache JD, Rhoades HM. Predictors of individual differences in alprazolam self-medication. Experimental and Clinical Psychopharmacology. 7: 379-90. PMID 10609973 DOI: 10.1037//1064-1297.7.4.379  0.32
1999 Johnson BA, Roache JD, Bordnick PS, Ait-Daoud N. Isradipine, a dihydropyridine-class calcium channel antagonist, attenuates some of d-methamphetamine's positive subjective effects: A preliminary study Psychopharmacology. 144: 295-300. PMID 10435398 DOI: 10.1007/S002130051007  0.32
1997 Spiga R, Macenski MJ, Meisch RA, Roache JD. Human ethanol self-administration I: The interaction between response requirement and ethanol dose Behavioural Pharmacology. 8: 91-100. PMID 9833005 DOI: 10.1097/00008877-199702000-00010  0.32
1997 Grabowski J, Roache JD, Schmitz JM, Rhoades H, Creson D, Korszun A. Replacement medication for cocaine dependence: Methylphenidate Journal of Clinical Psychopharmacology. 17: 485-488. PMID 9408812 DOI: 10.1097/00004714-199712000-00008  0.32
1997 Mintzer MZ, Guarino J, Kirk T, Roache JD, Griffiths RR. Ethanol and pentobarbital: comparison of behavioral and subjective effects in sedative drug abusers. Experimental and Clinical Psychopharmacology. 5: 203-15. PMID 9260068 DOI: 10.1037/1064-1297.5.3.203  0.32
1996 Streufert S, Satish U, Pogash R, Gingrich D, Landis JR, Lonardi L, Miller J, Severs W, Roache JD. Effects of alprazolam on complex human functioning Journal of Applied Social Psychology. 26: 1912-1930. DOI: 10.1111/J.1559-1816.1996.Tb00105.X  0.32
1996 Roache JD, Stanley MA, Creson DL, Meisch RA, Shah NN. Diazepam reinforcement in anxious patients Experimental and Clinical Psychopharmacology. 4: 308-314. DOI: 10.1037//1064-1297.4.3.308  0.32
1996 Pearson DA, Santos CW, Roache JD, Loveland KA, Casat CD, Farwell EC, Roebuck TM, Lachar D. Effects of methylphenidate on behavioral adjustment in children with mental retardation and ADHD: Preliminary findings from a study in progress Journal of Developmental and Physical Disabilities. 8: 313-333. DOI: 10.1007/Bf02578398  0.32
1995 Roache JD, Meisch RA, Henningfield JE, Jaffe JH, Klein S, Sampson A. Reinforcing effects of triazolam in sedative abusers: Correlation of drug liking and self-administration measures Pharmacology, Biochemistry and Behavior. 50: 171-179. PMID 7740055 DOI: 10.1016/0091-3057(94)00281-M  0.32
1995 Streufert S, Pogash R, Miller J, Gingrich D, Landis R, Lonardi L, Severs W, Roache JD. Effects of caffeine deprivation on complex human functioning. Psychopharmacology. 118: 377-84. PMID 7568623 DOI: 10.1007/Bf02245937  0.32
1994 Dougherty DM, Cherek DR, Roache JD. The effects of smoked marijuana on progressive-interval schedule performance in humans Journal of the Experimental Analysis of Behavior. 62: 73-87. PMID 8064214 DOI: 10.1901/Jeab.1994.62-73  0.32
1994 Stewart RB, Lemaire GA, Roache JD, Meisch RA. Establishing benzodiazepines as oral reinforcers: midazolam and diazepam self-administration in rhesus monkeys. The Journal of Pharmacology and Experimental Therapeutics. 271: 200-11. PMID 7965716  0.32
1993 Griffiths RR, Evans SM, Guarino JJ, Roache JD, Furman WR, Liebson I, Schwam EM. Intravenous flumazenil following acute and repeated exposure to lorazepam in healthy volunteers: Antagonism and precipitated withdrawal Journal of Pharmacology and Experimental Therapeutics. 265: 1163-1174. PMID 8510001  0.32
1993 Roache JD, Cherek DR, Bennett RH, Schenkler JC, Cowan KA. Differential effects of triazolam and ethanol on awareness, memory, and psychomotor performance Journal of Clinical Psychopharmacology. 13: 3-15. PMID 8486815 DOI: 10.1097/00004714-199302000-00002  0.32
1993 Roache JD, Spiga R, Burt DB. Triazolam and ethanol effects on human matching-to-sample performance vary as a function of pattern size and discriminability Drug and Alcohol Dependence. 32: 219-229. PMID 8348874 DOI: 10.1016/0376-8716(93)90086-6  0.32
1993 Cherek DR, Roache JD, Egli M, Davis C, Spiga R, Cowan K. Acute effects of marijuana smoking on aggressive, escape and point-maintained responding of male drug users Psychopharmacology. 111: 163-168. PMID 7870947 DOI: 10.1007/Bf02245518  0.32
1993 Roache JD, Cherek DR, Meisch RA, Spiga R. Effects of reinforcement history on benzodiazepine disruption of matching- to-sample (MTS) performance Nida Research Monograph Series. 273.  0.32
1991 Cherek DR, Spiga R, Roache JD, Cowan KA. Effects of triazolam on human aggressive, escape and point-maintained responding Pharmacology, Biochemistry and Behavior. 40: 835-839. PMID 1816570 DOI: 10.1016/0091-3057(91)90094-I  0.32
1991 ROACHE JD. Performance and physiological measures in abuse liability evaluation British Journal of Addiction. 86: 1595-1600. PMID 1786492 DOI: 10.1111/J.1360-0443.1991.Tb01753.X  0.32
1990 Spiga R, Cherek DR, Roache JD, Cowan KA. The effects of codeine on human aggressive responding International Clinical Psychopharmacology. 5: 195-204. PMID 2230064 DOI: 10.1097/00004850-199007000-00005  0.32
1990 Kirk T, Roache JD, Griffiths RR. Dose-response evaluation of the amnestic effects of triazolam and pentobarbital in normal subjects Journal of Clinical Psychopharmacology. 10: 160-167. PMID 2198294 DOI: 10.1097/00004714-199006000-00002  0.32
1990 Roache JD, Cherek DR, Spiga R, Bennett RH, Cowan KA, Yingling J. Benzodiazepine-induced impairment of matching-to-sample performance in humans Pharmacology, Biochemistry and Behavior. 36: 945-952. PMID 1977179 DOI: 10.1016/0091-3057(90)90104-P  0.32
1990 Roache JD. Addiction potential of benzodiazepines and non-benzodiazepine anxiolytics Advances in Alcohol and Substance Abuse. 9: 103-128. PMID 1974120 DOI: 10.1300/J251V09N01_07  0.32
1989 Spiga R, Cherek DR, Roache JD, Cowan K. The acute effects of codeine on human aggressive and non-aggressive behavior Nida Research Monograph Series. 479-480. PMID 2701320  0.32
1989 Guarino JJ, Roache JD, Kirk WT, Griffiths RR. Comparison of the behavioral effects and abuse liability of ethanol and pentobabital in recreational sedative abusers Nida Research Monograph Series. 453-454. PMID 2701315  0.32
1989 Spiga R, Cherek DR, Meisch RA, Roache JD. Human multioperant responding: Effects of triazolam Nida Research Monograph Series. 477-478. PMID 2641038  0.32
1989 Roache JD, Cherek DR, Cowan KA, Spiga R, Bennett RH, Grabowski J. Effects of triazolam (TZ) on matching-to-sample (MTS) performance in humans Nida Research Monograph Series. 475-476. PMID 2641037  0.32
1989 Bennett RH, Cherek DR, Roache JD, Rose JE. Effects of controlled nicotine doses upon punished and non-punished responding in humans. Nida Research Monograph. 95: 438-9. PMID 2641021  0.32
1989 Cherek DR, Bennett RH, Roache JD, Grabowski J. Human aggressive and non-aggressive responding during acute tobacco abstinence Nida Research Monograph Series. 435-436. PMID 2641020  0.32
1989 Roache JD, Griffiths RR. Diazepam and triazolam self-administration in sedative abusers: concordance of subject ratings, performance and drug self-administration Psychopharmacology. 99: 309-315. PMID 2594898 DOI: 10.1007/Bf00445549  0.32
1989 Roache JD, Griffiths RR. Abuse liability of anxiolytics and sedative/hypnotics: methods assessing the likelihood of abuse Nida Research Monograph. 92: 123-146. PMID 2574414  0.32
1987 Griffiths RR, Ator NA, Roache JD, Lamb RJ. Abuse liability of triazolam: experimental measurements in animals and humans. Psychopharmacology Series. 3: 83-7. PMID 3823094 DOI: 10.1007/978-3-642-71288-3_10  0.32
1987 Roache JD, Griffiths RR. Lorazepam and meprobamate dose effects in humans: Behavioral effects and abuse liability Journal of Pharmacology and Experimental Therapeutics. 243: 978-988. PMID 3694540  0.32
1987 Roache JD, Griffiths RR. Interactions of diazepam and caffeine: Behavioral and subjective dose effects in humans Pharmacology, Biochemistry and Behavior. 26: 801-812. PMID 3602037 DOI: 10.1016/0091-3057(87)90614-9  0.32
1987 Cone EJ, Roache JD, Johnson RE. Effects of passive exposure to marijuana smoke Nida Research Monograph. 76: 150-156. PMID 2830518  0.32
1986 Roache JD, Griffiths RR. Repeated administration of diazepam and triazolam to subjects with histories of drug abuse Drug and Alcohol Dependence. 17: 15-29. PMID 3720528 DOI: 10.1016/0376-8716(86)90032-3  0.32
1986 Griffiths RR, Brady JV, Ator NA, Lamb R, Bigelow GE, Roache JD. Progress report from the Division of Behavioral Biology, the Johns Hopkins University School of Medicine. Nida Research Monograph. 67: 93-7. PMID 3092102  0.32
1986 Roache JD, Zabik JE. Effects of benzodiazepines on taste aversions in a two-bottle choice paradigm Pharmacology, Biochemistry and Behavior. 25: 431-437. PMID 3020595 DOI: 10.1016/0091-3057(86)90020-1  0.32
1986 Cone EJ, Johnson RE, Moore JD, Roache JD. Acute effects of smoking marijuana on hormones, subjective effects and performance in male human subjects Pharmacology, Biochemistry and Behavior. 24: 1749-1754. PMID 3016764 DOI: 10.1016/0091-3057(86)90515-0  0.32
1985 Roache JD, Griffiths RR. Comparison of triazolam and pentobarbital: Performance impairment, subjective effects and abuse liability Journal of Pharmacology and Experimental Therapeutics. 234: 120-133. PMID 2861282  0.32
1985 Griffiths RR, Lamb RJ, Ator NA, Roache JD, Brady JV. Relative abuse liability of triazolam: experimental assessment in animals and humans. Neuroscience and Biobehavioral Reviews. 9: 133-51. PMID 2858078 DOI: 10.1016/0149-7634(85)90039-9  0.32
1985 Roache JD, Griffiths RR. Experimental assessment of the relative abuse liability of triazolam and pentobarbital Nida Research Monograph Series. 106-110.  0.32
1985 Griffiths RR, Bigelow GE, Liebson IA, Roache JD. Dose effect and preference comparison of diazepam and oxazepam Nida Research Monograph Series. 97-98.  0.32
1985 Roache JD, Griffiths RR. Differential tolerance development to diazepam (DZ) and Triazolam (TZ) Federation Proceedings. 44.  0.32
1984 Griffiths RR, McLeod DR, Bigelow GE, Liebson IA, Roache JD, Nowowieski P. Comparison of diazepam and oxazepam: Preference, liking and extent of abuse Journal of Pharmacology and Experimental Therapeutics. 229: 501-508. PMID 6716272  0.32
1984 Griffiths RR, McLeod DR, Bigelow GE, Liebson IA, Roache JD. Relative abuse liability of diazepam and oxazepam: Behavioral and subjective dose effects Psychopharmacology. 84: 147-154. PMID 6438672 DOI: 10.1007/Bf00427437  0.32
1984 Roache JD, Griffiths RR. Subjective and amnesic effects of triazolam (TZ) and pentobarbital (PB) Federation Proceedings. 43.  0.32
1983 Zabik JE, Roache JD. 5-Hydroxytryptophan-induced conditioned taste aversion to ethanol in the rat Pharmacology, Biochemistry and Behavior. 18: 785-790. PMID 6304784 DOI: 10.1016/0091-3057(83)90023-0  0.32
1983 Zabik JE, Roache JD, Johnson W. Dependence liability of caffeine, cocaine, nicotine and phencyclidine Research Communications in Substances of Abuse. 4: 93-96.  0.32
1980 Roache JD, Zabik JE. Factors affecting 5-hydroxytryptophan (5-HTP)-induced long term aversion to ethanol in rats Pharmacologist. 22: 370.  0.32
1979 Zabik JE, Roache JD. The inhibitory effects of 5-hydroxytryptophan (5HTP) on ethanol consumption in fluid deprived rats Federation Proceedings. 38.  0.32
Show low-probability matches.